- Home
- CHRO vs GURE Comparison
CHRO vs GURE Comparison
Compare CHRO & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- GURE
- Stock Information
- Founded
- CHRO 2002
- GURE 2006
- Country
- CHRO United States
- GURE China
- Employees
- CHRO N/A
- GURE N/A
- Industry
- CHRO
- GURE Major Chemicals
- Sector
- CHRO
- GURE Industrials
- Exchange
- CHRO Nasdaq
- GURE Nasdaq
- Market Cap
- CHRO 8.4M
- GURE 8.0M
- IPO Year
- CHRO 2024
- GURE 1992
- Fundamental
- Price
- CHRO $0.95
- GURE $0.64
- Analyst Decision
- CHRO Strong Buy
- GURE
- Analyst Count
- CHRO 1
- GURE 0
- Target Price
- CHRO N/A
- GURE N/A
- AVG Volume (30 Days)
- CHRO 2.1M
- GURE 1.0M
- Earning Date
- CHRO 05-13-2025
- GURE 05-13-2025
- Dividend Yield
- CHRO N/A
- GURE N/A
- EPS Growth
- CHRO N/A
- GURE N/A
- EPS
- CHRO N/A
- GURE N/A
- Revenue
- CHRO N/A
- GURE $7,958,395.00
- Revenue This Year
- CHRO N/A
- GURE N/A
- Revenue Next Year
- CHRO N/A
- GURE N/A
- P/E Ratio
- CHRO N/A
- GURE N/A
- Revenue Growth
- CHRO N/A
- GURE N/A
- 52 Week Low
- CHRO $0.45
- GURE $0.50
- 52 Week High
- CHRO $3.80
- GURE $1.79
- Technical
- Relative Strength Index (RSI)
- CHRO 35.68
- GURE 45.38
- Support Level
- CHRO $0.91
- GURE $0.56
- Resistance Level
- CHRO $1.14
- GURE $0.69
- Average True Range (ATR)
- CHRO 0.12
- GURE 0.04
- MACD
- CHRO -0.01
- GURE 0.00
- Stochastic Oscillator
- CHRO 17.04
- GURE 60.31
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.